If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

Holding(s) in Company

22 Mar 2007 14:57

H&T Group PLC22 March 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: H&T Group plc - GB00B12RQD06 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( X ) Other (please specify) : ( ) ................. 3. Full name of person(s) subject to the notification obligation: UBS Global Asset Management - Traditional 4. Full name of shareholder(s) (if different from 3.) : UBS Global Asset Management (UK) Limited UBS Global Asset Management Life Limited 5. Date of the transaction (and date on which the threshold is crossed orreached if different): 16 March 2007 (See 13. Additional information) 6. Date on which issuer notified: 20 March 2007 7. Threshold(s) that is/are crossed or reached: 9.20% 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering transactionusing the ISIN CODE Number of shares Number of voting Rights GB00B12RQD06 2,310,707 2,310,707 Resulting situation after the triggering transaction Class/type of shares if Number of shares Number of voting rights % of voting rightspossible using the ISIN CODE Direct Direct Indirect Direct Indirect GB00B12RQD06 2,896,976 2,310,707 586,269 7.33% 1.86% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rightsfinancial Period/ Date that may be acquired if theinstrument instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 2,896,976 9.20% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable : UBS Global Asset Management (UK) Limited - 586,269- 1.86% UBS Global Asset Management Life Limited - 2,310,707 - 7.33% Proxy Voting: 10. Name of the proxy holder: UBS Global Asset Management on behalf of a number of asset management clients 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: This disclosure has been made to fulfil the below FSA requirement: The Transparency Directive states that where a major shareholder has not beenrequired (because of an acquisition or disposal of voting rights or due to achange in the total of voting rights in issue) to make an announcement to theissuer prior to the 20th March 2007, then we must do so by that date in anyevent. Please note that UBS are no longer required to include prime brokerage holdingsin the disclosures under DTR5. 14. Contact name: Angela Huff, Associate Director, UBS AG 15. Contact telephone number: 0207 568 4981 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Aug 20207:00 amRNSUNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS
22nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSH&T appoints Chris Gillespie as executive director
29th Jun 20207:00 amRNSCOVID-19 update
23rd Jun 20201:36 pmRNSNotification of major holdings
11th Jun 20208:44 amRNSNotice of Annual Report Posting
18th May 20207:00 amRNSAGM Results
23rd Apr 20207:00 amRNSDirector Dealings and Issue of Equity
6th Apr 20207:00 amRNSCOVID-19 Update
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSAnnual Financial Report
27th Jan 20207:00 amRNSTrading Update and Notice of Results
14th Jan 20207:00 amRNSBoard changes
19th Nov 201912:39 pmRNSNotification of major holdings
18th Nov 20197:00 amRNSFCA review
8th Nov 20194:40 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
7th Nov 20194:40 pmRNSSecond Price Monitoring Extn
7th Nov 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20191:28 pmRNSAdditional Listing
30th Sep 20194:43 pmRNSAcquisition & Trading
18th Sep 20197:00 amRNSExecutive Director
5th Sep 20193:39 pmRNSAdditional Listing
13th Aug 20197:00 amRNSUnaudited Interim Condensed Financial Statements
7th Aug 20192:00 pmRNSNotice of Results
22nd Jul 20193:42 pmRNSFinancial Director
22nd Jul 201911:15 amRNSStephen Fenerty
12th Jul 20191:59 pmRNSNotification of Major Holdings
5th Jul 20195:39 pmRNSNotification of Major Holdings
2nd Jul 20197:00 amRNSResult of Placing
1st Jul 20194:35 pmRNSAcquisition and Placing
21st Jun 20197:00 amRNSNotice of Annual Report Posting
3rd May 20197:00 amRNSResult of AGM
23rd Apr 20197:00 amRNSAdditional Listing
4th Apr 20194:00 pmRNSDirector dealings and issue of equity
12th Mar 20197:00 amRNSPreliminary Results
23rd Jan 20197:00 amRNSTrading Update and Notice of Results
3rd Jan 20197:00 amRNSPerformance Share Plan Awards
21st Nov 20184:21 pmRNSNotification of Major Holdings
10th Oct 201812:00 pmRNSNotification of Major Holdings
11th Sep 20187:00 amRNSDirector/PDMR Shareholding
14th Aug 20187:00 amRNSInterim Results
27th Jul 20184:23 pmRNSIFRS 9 Transition Document
16th Jul 20184:18 pmRNSNotification of Major Holdings
20th Jun 201810:25 amRNSAdditional Listing
14th Jun 20185:32 pmRNSDirector Dealings
13th Jun 201812:19 pmRNSDirector Dealings
29th May 20184:14 pmRNSNotification of Major Holdings
29th May 20187:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.